Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women

Oncology Reports

Volumn 14, Issue 2, 2005, Pages 459-464

  Kim, Yong Beom ^a   Song, Yong Sang ^a   Jeon, Yong Tark ^a   Park, Jong Sup ^b   Um, Soo Jong ^c   Kim, Jae Weon ^a   Park, Noh Hyun ^a   Kang, Soon Beom ^a   Lee, Hyo Pyo ^a  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Sejong University   (South Korea)

Author keywords

Human papillomavirus 16; Sequence variation; Transcriptional activity; Upstream regulatory region

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; HYBRID PROTEIN; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; VIRUS DNA;

ARTICLE; CHEMISTRY; DNA SEQUENCE; FEMALE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; KOREA; METABOLISM; PATHOLOGY; POINT MUTATION; REGULATORY SEQUENCE; TUMOR CELL LINE; UTERINE CERVIX TUMOR; VIROLOGY;

CELL LINE, TUMOR; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA, VIRAL; FEMALE; HUMANS; KOREA; ONCOGENE PROTEINS, VIRAL; POINT MUTATION; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 24744441531     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.2.459     Document Type: Article

References (29)

1. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A and zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111-114, 1985. (Pubitemid 15142033)
2. McBride AA, Romanczuk H and Howley PM: The papillomavirus E2 regulatory proteins. J Biol Chem 266: 18411-18414, 1991. (Pubitemid 21908095)
3. Zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9-13, 1991.
4. Cullen AP, Reid R, Campion M and Lorincz AT: Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 65: 606-612, 1991.
5. Beaudenon S, Kremsdorf D, Croissant O, Jablonska S, Wain-Hobson S and Orth G: A novel type of human papillomavirus associated with genital neoplasias. Nature 321: 246-249, 1986. (Pubitemid 16016418)
6. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK and Kiviat NB: Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89: 796-802, 1997. (Pubitemid 27242281)
7. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G and Madrigal-De la Campa A: Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93: 1325-1330, 2001. (Pubitemid 32910573)
8. May M, Dong XP, Beyer-Finkler E, Stubenrauch F, Fuchs PG and Pfister H: The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J 13: 1460-1466, 1994. (Pubitemid 24090228)
9. Dong XP, Stubenrauch F, Beyer-Finkler E and Pfister H: Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 58: 803-808, 1994. (Pubitemid 24306367)
10. Watts KJ, Thompson CH, Cossart YE and Rose BR: Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. Int J Cancer 97: 868-874, 2002. (Pubitemid 34106347)
11. Kurvinen K, Yliskoski M, Saarikoski S, Syrjanen K and Syrjanen S: Variants of the long control region of human papillomavirus type 16. Eur J Cancer 36: 1402-1410, 2000. (Pubitemid 30421145)
12. Kammer C, Tommasino M, Syrjanen S, Delius H, Hebling U, Warthorst U, Pfister H and Zehbe I: Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 86: 269-273, 2002. (Pubitemid 34185157)
13. Seedorf K, Krammer G, Durst M, Suhai S and Rowekamp WG: Human papillomavirus type 16 DNA sequence. Virology 145: 181-185, 1985. (Pubitemid 15234421)
14. Song YS, Kee SH, Kim JW, Park NH, Kang SB, Chang WH and Lee HP: Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and non-cancerous lesions of Korean women. Gynecol Oncol 66: 275-281, 1997. (Pubitemid 27335417)
15. Bavin PJ, Walker PG and Emery VC: Sequence microheterogeneity in the long control region of clinical isolates of human papillomavirus type 16. J Med Virol 39: 267-272, 1993. (Pubitemid 23128418)
16. Park JS, Hwang ES, Lee CJ, Kim CJ, Rha JG, Kim SJ, Namkoong SE and Um SJ: Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia. Gynecol Oncol 74: 23-29, 1999. (Pubitemid 29331163)
17. O'Connor MJ, Stunkel W, Koh CH, Zimmermann H and Bernard HU: The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J Virol 74: 401-410, 2000. (Pubitemid 30002921)
18. Sambrook J, Fritsch EF and Maniatis T: Molecular cloning; A laboratory Manual. Cold Spring Harbor Laboratory Press., Cold Spring Harbor, 1989.
19. Wheeler CM, Yamada T, Hildesheim A and Jenison SA: Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35: 11-19, 1997. (Pubitemid 26422621)
20. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX and Wheeler CM: Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71: 2463-2472, 1997. (Pubitemid 27078630)
21. Ho L, Chan SY, Burk RD, et al: The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67: 6413-6423, 1993. (Pubitemid 23309105)
22. OConner M, Chan SY and Bernard HU: Transcriptional factor binding sites in the long control region of genital HPVs. In: Human Papillomaviruses 1995. Myers G, Bernard HU, Backer C, Halpern A, Delius H and Icenogle J (eds). Los Alamos Laboratory, ppIII 21-III 40, 1995.
23. Hoppe-Seyler F, Butz K and zur Hausen H: Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. Virol 65: 5613-5618, 1991.
24. Chen Z, Storthz KA and Shillitoe EJ: Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Res 57: 1614-1619, 1997. (Pubitemid 27175583)
25. Bauknecht T, Angel P, Royer HD and zur Hausen H: Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J 11: 4607-4617, 1992.
26. Dong XP and Pfister H: Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16. J Gen Virol 80: 2097-2101, 1999.
27. Watts KJ, Thompson CH, Cossart YE and Rose BR: Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia. J Clin Microbiol 39: 2009-2014, 2001. (Pubitemid 32417067)
28. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL and Bernard HU: Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 29: 1765-1772, 1991.
29. Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM and Pfister H: Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81: 1975-1981, 2000. (Pubitemid 30599178)